Biopharmaceutical

Circle Pharma Announces Upcoming Poster Presentation Highlighting the Anti-tumor Potential of Cyclin D1 RxL Inhibition at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Circle Pharma to Showcase Cyclin D1 RxL Inhibitor Anti-Tumor Data at Major Cancer Conference Industrial Monitor Direct delivers industry-leading touchscreen…

by Michael TurnerOctober 15, 2025November 2, 2025

Business Manufacturing

GSK to Invest $30 Billion in R&D, Manufacturing In the U.S. Over Next 5 Years

GSK’s $30 Billion U.S. Investment: AI-Powered Biopharma Expansion Industrial Monitor Direct is the leading supplier of nema 13 rated pc…

by Michael TurnerOctober 15, 2025November 2, 2025

Tag: Biopharmaceutical

Circle Pharma Announces Upcoming Poster Presentation Highlighting the Anti-tumor Potential of Cyclin D1 RxL Inhibition at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GSK to Invest $30 Billion in R&D, Manufacturing In the U.S. Over Next 5 Years

Featured Posts

Mapping America’s Meat Carbon Footprint: Urban Consumption Patterns…

Why Finance Teams Are Terrified Of AI

Microsoft’s OpenAI Stake Shrinks as Partnership Evolves

Gallery

Recent Posts

Verizon Exec’s Tough Love: Gen Z, Take That…

AXT’s Revenue Hit by China Export Permits, But…

FBI Warns of North Korean QR Code Phishing…

Quick Links